anke augspach
@ankeaugspach.bsky.social
Precision oncology researcher specializing in minor intron splicing, with a particular focus on prostate and breast cancer.
“If opportunity doesn’t knock, build a door.” – Milton Berle
@rahulkanadia.bsky.social ky.social, @marubin1.bsky.social and I have launched Verintas Therapeutics Inc.
to target the minor spliceosome in cancer.
Thanks to Nextwave X Partners-our 1st investor and believer.
#Verintas #minorspliceosome
@rahulkanadia.bsky.social ky.social, @marubin1.bsky.social and I have launched Verintas Therapeutics Inc.
to target the minor spliceosome in cancer.
Thanks to Nextwave X Partners-our 1st investor and believer.
#Verintas #minorspliceosome
August 17, 2025 at 5:32 PM
“If opportunity doesn’t knock, build a door.” – Milton Berle
@rahulkanadia.bsky.social ky.social, @marubin1.bsky.social and I have launched Verintas Therapeutics Inc.
to target the minor spliceosome in cancer.
Thanks to Nextwave X Partners-our 1st investor and believer.
#Verintas #minorspliceosome
@rahulkanadia.bsky.social ky.social, @marubin1.bsky.social and I have launched Verintas Therapeutics Inc.
to target the minor spliceosome in cancer.
Thanks to Nextwave X Partners-our 1st investor and believer.
#Verintas #minorspliceosome
In cancer research, we chase the “untreatable” — but making current treatments more tolerable matters too. Grateful to the SwissLife Jubiläumsstiftung for supporting my work on minor spliceosome-based co-treatments to ease side effects and improve outcomes.
#swisslife #minorspliceosome #RNAbaseddrug
#swisslife #minorspliceosome #RNAbaseddrug
June 2, 2025 at 12:01 PM
In cancer research, we chase the “untreatable” — but making current treatments more tolerable matters too. Grateful to the SwissLife Jubiläumsstiftung for supporting my work on minor spliceosome-based co-treatments to ease side effects and improve outcomes.
#swisslife #minorspliceosome #RNAbaseddrug
#swisslife #minorspliceosome #RNAbaseddrug
:)
Europe’s choice is clear.
To put science at the heart of its economy.
To become the home of scientific freedom and collaboration.
And to welcome talent from all over the world.
I’m glad to present the first elements of our Choose Europe Initiative.
→ europa.eu/!TTbWbJ
To put science at the heart of its economy.
To become the home of scientific freedom and collaboration.
And to welcome talent from all over the world.
I’m glad to present the first elements of our Choose Europe Initiative.
→ europa.eu/!TTbWbJ
May 6, 2025 at 9:35 AM
:)
Reposted by anke augspach
We will put forward a 500 million package for 2025-2027 to make Europe a magnet for researchers.
As well as ambitious proposals for R&I in the next EU budget.
We will also offer the best and brightest the right incentives to come to Europe ↓
As well as ambitious proposals for R&I in the next EU budget.
We will also offer the best and brightest the right incentives to come to Europe ↓
May 5, 2025 at 10:02 AM
We will put forward a 500 million package for 2025-2027 to make Europe a magnet for researchers.
As well as ambitious proposals for R&I in the next EU budget.
We will also offer the best and brightest the right incentives to come to Europe ↓
As well as ambitious proposals for R&I in the next EU budget.
We will also offer the best and brightest the right incentives to come to Europe ↓
Reposted by anke augspach
Bluesky is the place for science.
Mike spotted this before the rest of us. 🫡
Publications from 2025 are shared more on Bluesky than on X/Twitter.
Publications from 2025 are shared more on Bluesky than on X/Twitter.
About to talk to medical affairs colleagues, with the news that Bluesky is carrying more posts about new journal publications than X #bluesky #altmetrics #x #xparrot
March 13, 2025 at 11:01 PM
Bluesky is the place for science.